Sun Pharma Advanced Research Co Ltd SPARC
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 99.79
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Sun Pharma Advanced Research Co Ltd is an Indian specialty and generic drug manufacturing company. The company has identified pharmaceuticals research and development as its only reportable segment. The company is focused on drug discovery in focused therapy areas such as cancer and anti-inflammatory treatments. The company considers merger and acquisition investment as a potential component of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities. It derives maximum revenue from India and also has its presence in othe4r countries.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Value
- Total Number of Employees
- 603
- Website
- https://www.sparc.life
Comparables
Valuation
|
Metric
|
SPARC
|
STAR
|
532296
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 188.30 | — |
Price/Book Value | 54.30 | 6.31 | 6.00 |
Price/Sales | 99.79 | 3.30 | 3.96 |
Price/Cash Flow | — | 27.25 | 3,188.04 |
Price/Earnings
SPARC
STAR
532296
Financial Strength
|
Metric
|
SPARC
|
STAR
|
532296
|
|---|---|---|---|
Quick Ratio | 0.81 | 0.55 | 0.75 |
Current Ratio | 1.02 | 1.03 | 1.28 |
Interest Coverage | −274.97 | 0.78 | 1.77 |
Quick Ratio
SPARC
STAR
532296
Profitability
|
Metric
|
SPARC
|
STAR
|
532296
|
|---|---|---|---|
Return on Assets (Normalized) | — | — | — |
Return on Equity (Normalized) | — | — | — |
Return on Invested Capital (Normalized) | — | — | — |
Return on Assets
SPARC
STAR
532296
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Htfnbyndv | Glzq | $86.1 Bil | |||
| Merck KGaA ADR
MKKGY
| Hvdkkfcbhm | Qpzbywr | $74.3 Bil | |||
| Haleon PLC ADR
HLN
| Gjnchwv | Nzq | $45.9 Bil | |||
| Viatris Inc
VTRS
| Sbjfkgrg | Bkgk | $13.8 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Gwgyvvds | Qtptt | $13.2 Bil | |||
| Catalent Inc
CTLT
| Svwnwmrbz | Mglrqp | $11.0 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Myxbfbn | Flxpdv | $3.4 Bil | |||
| Perrigo Co PLC
PRGO
| Mdnktztz | Hwbn | $3.4 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Dcgmdmwqh | Qdm | $2.4 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Flywlnvj | Rdrx | $2.2 Bil |
United States